SCHEMBL4583150

SCHEMBL4583150

CC12CC3CC(c4ccc(O)c(N)c4)(C1)CC(c1ccc(O)c(N)c1)(C3)C2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 7/20 0.44
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
POLB P06746 1/20 0.44
GFER P55789 1/20 0.44
ALDH1A1 P00352 10/20 0.36
ALOX15 P16050 4/20 0.36
HSD17B10 Q99714 4/20 0.36
PTPN11 Q06124 1/20 0.36
NR0B2 Q15466 1/20 0.36
EPHX2 P34913 1/20 0.36
PGR P06401 1/20 0.35
LMNA P02545 5/20 0.33
MAPT P10636 3/20 0.33
ALOX12 P18054 3/20 0.33
HTT P42858 3/20 0.33
RECQL P46063 2/20 0.33
PKM P14618 2/20 0.33
HIF1A Q16665 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2709672 0.86 PTPN11 (0.39) GAAMEN1KMT2APOLBGFER
SCHEMBL17042474 0.84 ESR1 (0.45) GAAMEN1KMT2APOLBGFER
SCHEMBL4583375 0.82 GAA (0.44) GAAMEN1KMT2APOLBGFER
SCHEMBL2709923 0.82 MEN1 (0.46) GAAMEN1KMT2APOLBGFER
SCHEMBL2708128 0.81 MEN1 (0.57) GAAMEN1KMT2APOLBGFER
SCHEMBL31544676 0.81 MEN1 (0.57) GAAMEN1KMT2APOLBGFER
SCHEMBL28207465 0.81 ESR1 (0.45) GAAMEN1KMT2APOLBGFER
SCHEMBL22453702 0.79 PTPN11 (0.45) GAAMEN1KMT2APOLBGFER
SCHEMBL4583386 0.79 MEN1 (0.41) GAAMEN1KMT2APOLBGFER
SCHEMBL17042615 0.78 PTPN11 (0.40) GAAMEN1KMT2APOLBGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423180-B2 Bis(3-amino-4-hydroxyphenyl)adamantane derivatives and process for production thereof IDEMITSU KOSAN CO., LTD. (JP) 2008-09-09 US disclosed
US-20060161016-A1 Bis(3-amino-4-hydroxyphenyl)adamantane derivatives and process for production thereof IDEMITSU KOSAN CO., LTD. (JP) 2006-07-20 US disclosed
EP-1602641-A1 BIS(3-AMINO-4-HYDROXYPHENYL)ADAMANTANE DERIVATIVES AND PROCESS FOR PRODUCTION THEREOF IDEMITSU KOSAN COMPANY LIMITED (JP) 2005-12-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060161016-A1 Bis(3-amino-4-hydroxyphenyl)adamantane derivatives and process for production thereof HTR3D, ALKBH3, ALKBH5 GAA 4851/4885MEN1 1616/4885KMT2A 1000/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.